GLP-1 agonists work by mimicking the incretin hormone GLP-1 , which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite
Related articles Boehringer Ingelheim Korea partners with 365mc to raise awareness of liver health in obese patients Boehringer inks AI protein-design research pact with Koreas Galux Boehringer Ingelheim Korea holds a forum for idiopathic pulmonary fibrosis patients Boehringer scales up fibrosis R&D across ASEAN, Korea, Australia, and NZ 'Boehringers new pulmonary fibrosis therapy shows promise, but access remains key challenge' Lee Han-soo [email protected]
Furthermore, standardized research materials help laboratories maintain consistency across ongoing investigations
It is not a magic fat burner
The main drug class of GLP-1 receptor agonist is liraglutide, dulaglutide, lixisenatide, and others
Bottiglieri T, Hyland K, Reynolds EH